Arcus Biosciences (NYSE:RCUS) reported its Q4 earnings results on Wednesday, February 21, 2024 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Arcus Biosciences missed estimated earnings by 5.88%, reporting an EPS of $-1.08 versus an estimate of $-1.02.
Revenue was down $3.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.2 which was followed by a 2.67% drop in the share price the next day.
Here's a look at Arcus Biosciences's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -1.14 | -1 | -1.16 | -1.07 |
EPS Actual | -0.94 | -1.04 | -1.09 | -0.93 |
Revenue Estimate | 27.28M | 35.86M | 24.97M | 23.31M |
Revenue Actual | 32.00M | 29.00M | 25.00M | 34.00M |
To track all earnings releases for Arcus Biosciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.